Fibrosis Completed Phase 2 Trials for Losartan (DB00678)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02049307Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV TrialTreatment